undefined

Tim Beyers

Motley Fool analyst discussing the Porsche IPO and Biogen's Alzheimer's drug.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app